钛媒体App 11月24日消息,诺和诺德的竞争对手渤健美股盘前拉升涨超6%。消息面上,诺和诺德公司称Evoke 3期试验未显示阿尔茨海默病进展的统计学显著减少。(科股宝播报)
Source Link钛媒体App 11月24日消息,诺和诺德的竞争对手渤健美股盘前拉升涨超6%。消息面上,诺和诺德公司称Evoke 3期试验未显示阿尔茨海默病进展的统计学显著减少。(科股宝播报)
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.